DK0736030T3 - Fungicide tetrahydrofuraner - Google Patents

Fungicide tetrahydrofuraner

Info

Publication number
DK0736030T3
DK0736030T3 DK95906620T DK95906620T DK0736030T3 DK 0736030 T3 DK0736030 T3 DK 0736030T3 DK 95906620 T DK95906620 T DK 95906620T DK 95906620 T DK95906620 T DK 95906620T DK 0736030 T3 DK0736030 T3 DK 0736030T3
Authority
DK
Denmark
Prior art keywords
independently
tetrahydrofurans
fungicidal
ester
polyestherester
Prior art date
Application number
DK95906620T
Other languages
Danish (da)
English (en)
Inventor
Ashit K Ganguly
Viyyoor M Girijavallabhan
Anil K Saksena
Raymond G Lovey
Yi-Tsung Liu
Russell E Pike
Haiyan Wang
Frank Bennett
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22622452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0736030(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0736030T3 publication Critical patent/DK0736030T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Lubricants (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
DK95906620T 1993-12-21 1994-12-20 Fungicide tetrahydrofuraner DK0736030T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17108393A 1993-12-21 1993-12-21
PCT/US1994/014236 WO1995017407A1 (en) 1993-12-21 1994-12-20 Tetrahydrofuran antifungals

Publications (1)

Publication Number Publication Date
DK0736030T3 true DK0736030T3 (da) 2001-10-29

Family

ID=22622452

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906620T DK0736030T3 (da) 1993-12-21 1994-12-20 Fungicide tetrahydrofuraner

Country Status (29)

Country Link
EP (1) EP0736030B1 (de)
JP (1) JP2834889B2 (de)
KR (1) KR0179990B1 (de)
CN (1) CN1064685C (de)
AT (1) ATE204875T1 (de)
AU (1) AU681753B2 (de)
BR (1) BR1100154B1 (de)
CA (1) CA2179396C (de)
CO (1) CO4520281A1 (de)
CZ (1) CZ294823B6 (de)
DE (2) DE122006000004I2 (de)
DK (1) DK0736030T3 (de)
ES (1) ES2159623T3 (de)
FI (1) FI118470B (de)
FR (1) FR06C0009I2 (de)
HK (1) HK1008820A1 (de)
HU (1) HU225062B1 (de)
IL (1) IL112081A (de)
LU (1) LU91216I2 (de)
MY (1) MY130217A (de)
NL (1) NL300219I2 (de)
NO (2) NO316173B1 (de)
NZ (1) NZ278713A (de)
PL (1) PL181193B1 (de)
PT (1) PT736030E (de)
SK (1) SK283035B6 (de)
TW (1) TW377349B (de)
WO (1) WO1995017407A1 (de)
ZA (1) ZA9410142B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688455B2 (en) * 1994-01-24 1998-03-12 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
ES2199291T3 (es) * 1995-06-02 2004-02-16 Schering Corporation Antifungicos de tetrahidrofurano.
US5698557A (en) * 1995-06-19 1997-12-16 Schering Corporation Hydroxy-substituted antifungals
AU6257396A (en) * 1995-06-19 1997-01-15 Schering Corporation Tetrahydrofuran antifungals
CN1209116A (zh) * 1995-12-20 1999-02-24 先灵公司 制备酰肼类化合物的方法
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
PE68898A1 (es) * 1996-05-24 1998-11-10 Schering Corp Composiciones antihongo con biodisponibilidad mejorada
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
US5972381A (en) * 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
AU3483497A (en) * 1996-06-28 1998-01-21 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
JP2000514059A (ja) * 1996-06-28 2000-10-24 シェーリング コーポレイション トリアゾール抗真菌化合物を含む経口組成物
AU5432698A (en) 1996-11-12 1998-06-03 Sepracor, Inc. 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole
WO1998021203A1 (en) * 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,s,r- and 2s,4r,s,r-hydroxyitraconazole
EP0938484A1 (de) * 1996-11-12 1999-09-01 Sepracor, Inc. 2r,4s,r,r- und 2s,4r,r,r-hydroxyitraconazol
WO1998021213A2 (en) * 1996-11-12 1998-05-22 Sepracor, Inc. 2r,4s,r,s- and 2s,4r,r,s-hydroxyitraconazole- and hydroxysaperconazole derivatives
US5684197A (en) * 1996-12-12 1997-11-04 Schering Corporation Process for preparation of hydrazides
HU227744B1 (en) 1997-02-11 2012-02-28 Janssen Pharmaceutica Nv Amino acid ester containing azole antifungals, process for their preparation, pharmaceuticals containing the same and intermediates
US6043245A (en) * 1997-09-25 2000-03-28 Schering Corporation Tetrahydrofuran antifungal phosphate
IL134469A0 (en) * 1997-09-25 2001-04-30 Schering Corp Tetrahydrofuran phosphate- and hydroxy esters as prodrugs for the corrersponding antifungal agent
WO1999018111A1 (en) * 1997-10-07 1999-04-15 Schering Corporation Crystalline antifungal glycine ester polymorph
ATE263163T1 (de) * 1997-10-07 2004-04-15 Schering Corp Krytallinischer fungizider polymorph
US6713481B1 (en) * 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
EP0957101A1 (de) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Wasserlösliche Azole als Breitspektrum-antifungus
US6147077A (en) * 1999-04-29 2000-11-14 Sepracor Inc. 2R,4S-hydroxyitraconazole isomers
BR0010279A (pt) 1999-05-04 2002-05-14 Janssen Phamaceutica N V éteres antifúngicos
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
AU2002257104B2 (en) 2001-04-03 2006-02-09 Merck Sharp & Dohme Corp. Antifungal composition with enhanced bioavailability
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7078526B2 (en) 2002-05-31 2006-07-18 Transform Pharmaceuticals, Inc. CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
US7446107B2 (en) 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
CA2477923C (en) 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
MXPA05000232A (es) 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
ITMI20032020A1 (it) 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
PT1776109E (pt) * 2004-08-13 2009-03-25 Schering Plough Ltd Formulação farmacêutica que compreende um antibiótico, um triazol e um corticosteróide
EP2130540A1 (de) * 2008-06-02 2009-12-09 Sandoz AG Pharmazeutische Zusammensetzungen mit einer kristallinen Form von Posaconazol
EP2141159A1 (de) 2008-07-03 2010-01-06 Sandoz AG Kristalline Form von Posaconazol
EP2451805A1 (de) 2009-07-09 2012-05-16 Sandoz AG Kristalline form von posaconazol
WO2011158248A2 (en) * 2010-05-12 2011-12-22 Glenmark Generics Limited Process for preparation of posaconazole and crystalline polymorphic form v of posaconazole
EP2571847B1 (de) * 2010-05-19 2016-09-21 Sandoz AG Verfahren zur herstellung chiraler hydrazide
CN102906087B (zh) * 2010-05-19 2016-03-23 桑多斯股份公司 制备手性三唑酮的方法
RU2580318C2 (ru) * 2010-05-19 2016-04-10 Сандоз Аг Получение промежуточных продуктов для синтеза позаконазола
RU2585683C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Очистка позаконазола и промежуточных продуктов для синтеза позаконазола
ES2893444T3 (es) 2010-06-29 2022-02-09 Merck Sharp & Dohme Formulaciones de posaconazol en solución intravenosa estabilizadas mediante beta-ciclodextrina sustituida
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound
EP2789610A1 (de) 2013-04-10 2014-10-15 Sandoz Ag Reinigung von Posaconazol-Zwischenprodukten
EP3024828B1 (de) * 2013-07-25 2017-05-17 Sandoz AG Verbessertes verfahren zur herstellung von posaconazol in kristalliner iv-form
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN105287403A (zh) * 2014-08-02 2016-02-03 陕西合成药业股份有限公司 一种泊沙康唑前体药物的冻干组合物及其制备方法和用途
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
ES2786374T3 (es) 2014-12-05 2020-10-09 Pulmocide Ltd Compuesto antimicótico
HUE048843T2 (hu) * 2015-05-21 2020-08-28 Pulmocide Ltd Gombaölõ szer 4-(4-(4-(((3R,5R)-5-((1H -1,2,4-triazol-1-YL)metil)-5-(2,4-difluor-fenil)tetra-hidro-furán-3-YL)metoxi)-3 metilfenil)piperazin-1-il)-n -(2-hidroxi-ciklohexil)benzamid, vagy annak gyógyszerészetileg elfogadható sója
CN106317032A (zh) * 2015-06-15 2017-01-11 重庆圣华曦药业股份有限公司 一种制备高纯度的泊沙康唑的方法
CN106432338A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 泊沙康唑衍生物、合成和在长效制剂中的用途
JP7054381B2 (ja) * 2015-09-23 2022-04-13 バイオコン・リミテッド 結晶形態のポサコナゾール中間体および非晶質ポサコナゾールの調製のためのプロセス
CN105606736A (zh) * 2016-01-27 2016-05-25 重庆华邦制药有限公司 分离测定泊沙康唑中间体z1及其有关物质的方法
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
WO2018115319A2 (en) 2016-12-23 2018-06-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of cytochrome p450 family 7 subfamily b member 1 (cyp7b1) for use in treating diseases
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CN106967054A (zh) * 2017-03-30 2017-07-21 成都绿林科技有限公司 一种泊沙康唑的制备方法
CN106883221A (zh) * 2017-04-17 2017-06-23 兰州大学 一种无定形泊沙康唑及其制备方法
CN108341754A (zh) * 2018-03-12 2018-07-31 扬子江药业集团有限公司 泊沙康唑杂质及其制备方法和用途
CN110938093B (zh) * 2018-09-21 2022-08-19 华创合成制药股份有限公司 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途
CN112778369B (zh) * 2019-11-05 2024-01-26 华创合成制药股份有限公司 一种三唑类衍生物及其制备方法和用途
CN113666915B (zh) * 2021-08-27 2022-08-16 江苏海洋大学 一种泊沙康唑中间体的制备方法
CN114315811B (zh) * 2021-11-19 2024-04-30 江苏恒盛药业有限公司 一种三氮唑类似物化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
ES2065340T3 (es) * 1987-11-20 1995-02-16 Schering Corp Oxetanos y tetrahidrofuranos tri- y tetra-sustituidos y compuestos intermedios para los mismos.
US5039676A (en) * 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals

Also Published As

Publication number Publication date
FR06C0009I2 (de) 2006-12-29
NO2006002I1 (no) 2006-02-20
CZ294823B6 (cs) 2005-03-16
NZ278713A (en) 1997-12-19
JP2834889B2 (ja) 1998-12-14
IL112081A0 (en) 1995-03-15
SK283035B6 (sk) 2003-02-04
CN1142828A (zh) 1997-02-12
HUT75879A (en) 1997-05-28
IL112081A (en) 2001-08-26
HK1008820A1 (en) 1999-05-21
JPH09500658A (ja) 1997-01-21
WO1995017407A1 (en) 1995-06-29
HU9601709D0 (en) 1996-08-28
MY130217A (en) 2007-06-29
DE69428125D1 (de) 2001-10-04
CO4520281A1 (es) 1997-10-15
AU1512795A (en) 1995-07-10
PT736030E (pt) 2002-01-30
NO316173B1 (no) 2003-12-22
CZ180596A3 (en) 1997-01-15
NO962616L (no) 1996-08-07
CA2179396C (en) 2001-04-17
DE69428125T2 (de) 2002-05-02
DE122006000004I2 (de) 2007-03-29
NL300219I1 (nl) 2006-04-03
DE122006000004I1 (de) 2006-04-27
ES2159623T3 (es) 2001-10-16
NL300219I2 (nl) 2006-05-01
LU91216I2 (en) 2006-03-27
NO2006002I2 (no) 2011-03-07
FI962577A0 (fi) 1996-06-20
HU225062B1 (en) 2006-05-29
AU681753B2 (en) 1997-09-04
PL181193B1 (pl) 2001-06-29
NO962616D0 (no) 1996-06-20
ATE204875T1 (de) 2001-09-15
SK82696A3 (en) 1997-03-05
EP0736030B1 (de) 2001-08-29
EP0736030A1 (de) 1996-10-09
PL315169A1 (en) 1996-10-14
FR06C0009I1 (de) 2006-05-19
CA2179396A1 (en) 1995-06-29
KR0179990B1 (en) 1999-03-20
CN1064685C (zh) 2001-04-18
ZA9410142B (en) 1996-05-02
TW377349B (en) 1999-12-21
BR1100154B1 (pt) 2013-11-26
FI962577A (fi) 1996-06-20
FI118470B (fi) 2007-11-30

Similar Documents

Publication Publication Date Title
DK0736030T3 (da) Fungicide tetrahydrofuraner
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
MX9701229A (es) Antifungicos de tetrahidrofurano.
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
DE69629474D1 (de) Antifungale tetrahydrofurane
AU8226891A (en) Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
PT81556B (pt) Processo para a preparacao de agentes anti-fungicos de triazole
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
FI970452A (fi) Leukotrieenin biosynteesin estäminen ureajohdannaisten avulla
CO5011088A1 (es) Fosfato de tetrahidrofurano antifungal
AR003437A1 (es) Un compuesto antifungico de tetrahidrofurano, una composicion farmaceutica que los contiene, su uso para preparar un medicamento antifungico y una sal deester aminoacido del mismo